Randomized controlled trial of Olanzapine and Rikkunshito for anorexia causing anti malignant brain tumor drug.

Randomized controlled trial of Olanzapine and Rikkunshito for anorexia causing anti malignant brain tumor drug. - Randomized controlled trial of Olanzapine and Rikkunshito for anorexia causing anti malignant brain tumor drug.

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000044326

Enrollment

Registered

2021-05-26

Start date

2020-05-09

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malignant glioma

Interventions

Olanzapine Rikkunshito

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1)Patient of malignant glioma

Exclusion criteria

Exclusion criteria: 1)Deep coma 2)Uncontrollable Diabetes mellitus 3)Heavy liver dysfunction

Design outcomes

Primary

Measure	Time frame
QOL:EORTC QLQ-C308 Anolexia:Numerical Rating Scale Change of body weight, before and after treatment	—

Countries

Japan

Contacts

Public ContactKosuke Katayama

Hirosaki University Graduate School of Medicine Department of neurosurgery

k.kosuke@hirosaki-u.ac.jp+81-172-39-5115

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026